Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
If you want tighter expense control and explicit assignment of funds, zero based budgeting can be worth trying. This intro explains potential gains and a simple starting point.
26,943 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Ford stock surged 8% on Friday, easily outpacing General Motors and Stellantis as investors focus on Ford Energy and ...
Yatsen's Q1 2026 results are a pivotal signal for the year ahead. This analysis breaks down the earnings narrative, h...
Digital mortgage tools are reshaping how buyers shop for homes as rates swing and inventories stay tight. The latest ...
A mobile app rewards users for scrolling, propelling Mode Mobile into Deloitte’s fastest-growing software roster. Sha...
Rambus navigates a cooling memory-chip cycle that could weigh on margins even as AI infrastructure demand remains a k...
Coinbase and Better fund the first bitcoin-backed mortgage backed by Fannie Mae, aiming for a nationwide rollout with...
New data in 2026 cast doubt on the notion that ditching college ‘more secure’ automatically leads to a stable career,...
The House Ways and Means Committee plans a June hearing to decide if crypto tax relief should cover more than stablec...
Fidelity's 2026 study finds workers switch jobs about six times, leaving many with several old retirement accounts. F...
Broadcom posted a standout quarter, prompting elevated price targets and a renewed wave of institutional optimism, ev...
Celsius has moved into the spotlight as a growth play in beverages. This article lays out five practical reasons Cels...